Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.
Info & Links
CEO
Sean E. Brynjelsen
Headquarters
21925 W. FIELD PARKWAY, SUITE 235 DEER PARK, IL 60010, UNITED STATES
Eton Pharmaceutcials, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
390.30M
Enterprise Value
402.87M
Enterprise Value/EBITDA(ttm)
388.87
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
10.81
Price to Book(mrq)
23.26
Price to Cash(ytd)
4.50K
Profitability
Gross Margin(ttm)
58.93%
Operating Margin(ttm)
-15.81%
Profit Margin(ttm)
-10.42%
Return on Equity(ttm)
-36.29%
Return on Invested Capital(ttm)
-22.66%
Return on Assets(ttm)
-16.84%
Income Statement
Revenue(ttm)
48.33M
Revenue Per Share(ttm)
1.80
Gross Profit(ttm)
28.27M
EBITDA(ttm)3
1.04M
Net Income Available to Common(ttm)
-4.58M
Diluted EPS(ttm)
-0.22
Share Statistics
Beta (5Y Monthly)
1.40
52-Week Change
308.82%
S&P 500 52-Week Change
10.46%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
26.82M
Dividend Yield
0.00%
Float4
22.17M
% Held by Insiders
14.89%
% Held by Institutions
27.86%
Balance Sheet
Total Cash(mrq)
17.42M
Total Cash Per Share(mrq)
0.65
Total Debt(mrq)
29.99M
Total Debt/Equity(mrq)
122.67%
Current Ratio(mrq)
1.97%
Quick Ratio(mrq)
1.41%
Book Value Per Share(mrq)
0.91
Cash Flow
Operating Cash Flow Per Share(ytd)
0.08
Free Cash Flow(ytd)
2.09M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.